Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Muscle-Invasive Bladder Carcinoma × Taxes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 75 Pancreatic Neoplasms 72 Carcinoma, Non-Small-Cell Lung 62 Fallopian Tube Neoplasms 36 Ovarian Neoplasms 35 Triple Negative Breast Neoplasms 32 Neoplasm Metastasis 23 Lung Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 18 Breast Neoplasms, Male 16 Endometrial Neoplasms 15 Neoplasms 13 Brenner Tumor 13 Uterine Cervical Neoplasms 12 Stomach Neoplasms 12 Carcinoma, Ovarian Epithelial 12 Melanoma 11 Esophageal Neoplasms 11 Adenocarcinoma of Lung 9 Unspecified Adult Solid Tumor, Protocol Specific 8 Cholangiocarcinoma 8 Inflammatory Breast Neoplasms 7 Adenocarcinoma Of Esophagus 7 Urinary Bladder Neoplasms 6 Colorectal Neoplasms 6 Adenocarcinoma, Bronchiolo-Alveolar 6 Recurrence 5 Pancreatic Adenocarcinoma 5 Oropharyngeal Neoplasms 5 Mouth Neoplasms 5

Interventions

Nivolumab 3 Cisplatin 2 Albumin-Bound Paclitaxel 2 tislelizumab 1 spartalizumab 1 Taxes 1 Standard of Care 1 Radiotherapy 1 Neoadjuvant Therapy 1 Immunotherapy 1 Gemcitabine 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05203913 2024-10-04

CNN-BC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Recruiting

Muscle-Invasive Bladder Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡